Stocks in play: Fennec Pharmaceuticals Inc.
Will release its full-year and fourth-quarter 2023 financial results before the opening of the U.S. financial markets on Thursday, March 21. Fennec Pharmaceuticals Inc. shares T.FRX are trading unchanged at $13.18.
Read:
Global Efforts Intensify to Address Surging Young Adult Colorectal and Anal Cancer Rates
Harnessing AI's $4.4 Trillion Potential Reshapes the Tech Industry Landscape
Critical Push for US Domestic Nickel Needed to Halt Total Reliance on Questionable Foreign Imports
How Argentina’s New Power Moves Look to Lure Even More Lithium Interest Towards the Country
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer